The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMobeus I&g 4 Regulatory News (MIG4)

Share Price Information for Mobeus I&g 4 (MIG4)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 68.00
Bid: 66.50
Ask: 69.50
Change: 0.00 (0.00%)
Spread: 3.00 (4.511%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 68.00
MIG4 Live PriceLast checked at -
Mobeus Income & Growth 4 VCT is an Investment Trust

To provide investors with a regular income stream and to generate capital growth by investing primarily in a diverse portfolio of UK unquoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Offers for Subscription and Issue of Prospectus

5 Oct 2022 13:50

RNS Number : 9184B
Mobeus Income & Growth 4 VCT PLC
05 October 2022
 

Mobeus Income & Growth VCT plc (LEI: 213800HKOSEVWS7YPH79)

Mobeus Income & Growth 2 VCT plc (LEI: 213800LY62XLI1B4VX35)

Mobeus Income & Growth 4 VCT plc (LEI: 213800IFNJ65R8AQW943)

The Income & Growth VCT plc (LEI: 213800FPC15FNM74YD92)

 

Offers for Subscription and Issue of Prospectus

This announcement is made jointly by Mobeus Income & Growth VCT plc (MIG), Mobeus Income & Growth 2 VCT plc (MIG 2), Mobeus Income & Growth 4 VCT plc (MIG 4) and The Income & Growth VCT plc (I&G) (together the Companies and each a Company), which are advised by Gresham House Asset Management Limited (Gresham House).

The boards of the Companies are pleased to announce the launch of offers for subscription to raise, in aggregate, up to £47 million, with over-allotment facilities to raise, in aggregate, up to a further £29 million (together the Offers and each an Offer). The amount each Company is seeking to raise is set out below:

 

MIG

MIG 2

MIG 4

I&G

Maximum amount to be raised (excluding the over-allotment facility)

£14 million

£8 million

£11 million

£14 million

Maximum amount to be raised (including the over-allotment facility)

£22 million

£16 million

£16 million

£22 million

Full details of the Offers are contained in the prospectus issued by the Companies today (Prospectus). The Offers will open for applications at 9.00 a.m. on 17 October 2022 and will close for Applications (unless fully subscribed earlier or otherwise at the discretion of the relevant Board) at 5.30 p.m. on 27 March 2023. If a board decides (in consultation with Gresham House) to utilise its Company's over-allotment facility, this will be advised through a RIS announcement.

Investors can select which of the Companies they wish to invest in. Investors can apply to invest equally in all of the Companies or different amounts in one or more of the Companies (subject to an Offer not having closed prior to the application form being processed). The amount subscribed under each Offer will be invested into new ordinary shares of 1p each in the relevant Company.

Applications under an Offer will be accepted on a 'first-come, first-served' basis, subject always to the discretion of the relevant Company's board of directors. For these purposes 'first-come, first-served' shall be assessed based on the date and time of receipt of a fully completed application, subject to receipt of application monies (in full) in cleared funds within five business days thereafter to retain the applicant's position of priority.

The Prospectus, which has been approved by the Financial Conduct Authority, will shortly be available for download from the Companies' websites at:

· MIG: www.migvct.co.uk

· MIG 2: www.mig2vct.co.uk

· MIG 4: www.mig4vct.co.uk

· I&G: www.theincomeandgrowthvct.co.uk

The Prospectus will also shortly be available for inspection at the National Storage Mechanism, which is located at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

Pursuant to an offers' agreement dated 5 October 2022 relating to the Offers between, among others, each Company and Gresham House, each Company will pay Gresham House a fee of an amount representing 3.0% of the Investment Amounts (as defined in the Prospectus) in respect of applications accepted under its Offer, less an amount equal to (i) 0.5% of the Investment Amounts in respect of investors who receive advice from a financial adviser other than in respect of a Professional Client (as defined in the Prospectus) investor (and the application forms are completed by the financial adviser on this basis), (ii) 0.5% of the Investment Amounts where initial commission is waived by intermediaries in respect of applications from 'execution only' investors and Professional Client investors, (iii) 0.5% of the Investment Amounts in respect of direct investors who are existing shareholders in one or more of the Companies and (iv) any further amounts by which Gresham House agrees (at its discretion, but subject to not reducing Offer Costs (as defined in the Prospectus) to nil) to reduce its fees in respect of such applications, such amount being inclusive of VAT.

 

As Gresham House is a related party of each Company under the Listing Rules of the Financial Conduct Authority, the payment of such fee by each Company to Gresham House is a transaction to which Listing Rule 11.1.10 applies.

 

For further information, please contact:

Gresham House Asset Management Limited

Company Secretary

Telephone: +44 (0)20 7382 0999

 

 

 

Please note that the Mobeus VCTs and Gresham House cannot give any financial, legal, tax or investment advice.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIFLFSFIFLEIIF
Date   Source Headline
1st May 20247:00 amRNSTotal Voting Rights and Capital
26th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Apr 20247:00 amRNSAnnual Financial Report
2nd Apr 20249:30 amRNSTotal Voting Rights and Capital
22nd Mar 202410:02 amRNSDirector/PDMR Shareholding
22nd Mar 202410:00 amRNSIssue of Equity and Total Voting Rights
1st Mar 202411:00 amRNSTotal Voting Rights and Capital
28th Feb 20243:30 pmRNSMerger Discussions
27th Feb 20242:00 pmRNSRealisation of Investment: Master Removers Group
22nd Feb 202411:00 amRNSNet Asset Value(s)
6th Feb 20243:00 pmRNSDividend Declaration
1st Feb 202411:44 amRNSVoting Rights and Capital
2nd Jan 20241:00 pmRNSVoting Rights and Capital
21st Dec 202310:00 amRNSTransaction in Own Shares
1st Dec 20237:00 amRNSTotal Voting Rights
27th Nov 20237:00 amRNSTransaction in Own Shares
16th Nov 20232:00 pmRNSInterim Management Statement - replacement
15th Nov 20233:00 pmRNSInterim Management Statement
8th Nov 202310:35 amRNSDirector/PDMR Shareholding
8th Nov 202310:30 amRNSIssue of Equity and Total Voting Rights
1st Nov 20237:00 amRNSTotal Voting Rights
18th Oct 202310:00 amRNSTransaction in Own Shares
12th Oct 20237:00 amRNSStatement re Change of Registrar
5th Oct 20237:00 amRNSDividend Declaration
2nd Oct 20237:00 amRNSTotal Voting Rights
27th Sep 20237:00 amRNSHalf-year Report
22nd Sep 20237:00 amRNSDirector Declaration
1st Sep 20237:00 amRNSTotal Voting Rights
1st Aug 20237:00 amRNSTotal Voting Rights
26th Jul 20232:30 pmRNSInvestment Adviser Co-investment Incentive Scheme
3rd Jul 20237:00 amRNSTotal Voting Rights
28th Jun 202312:00 pmRNSTransaction in Own Shares
1st Jun 20237:00 amRNSTotal Voting Rights
26th May 20232:24 pmRNSDirector/PDMR Shareholding
26th May 202312:57 pmRNSIssue of Equity and Total Voting Rights
25th May 20237:00 amRNSResult of AGM
23rd May 20237:00 amRNSInterim Management Statement
2nd May 202310:00 amRNSTotal Voting Rights
19th Apr 20237:00 amRNSTransaction in Own Shares
13th Apr 20231:00 pmRNSDividend Declaration
6th Apr 20237:00 amRNSAnnual Financial Report
3rd Apr 20237:00 amRNSTotal Voting Rights
27th Mar 20231:00 pmRNSRealisation of investment: Tharstern Group Limited
1st Mar 20237:00 amRNSTotal Voting Rights
6th Feb 20235:28 pmRNSIssue of Equity and Total Voting Rights
1st Feb 20237:00 amRNSTotal Voting Rights
31st Jan 202311:08 amRNSIssue of Supplementary Prospectus
27th Jan 20232:00 pmRNSNet Asset Value(s)
16th Jan 20237:00 amRNSCHANGE OF ALLOTMENT DATE
22nd Dec 20229:34 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.